March 8, 2025 - 23:35

Amid limited access to pediatric dermatologists nationwide, pediatric patients of color with atopic dermatitis (AD) are particularly affected by social determinants of health, further impacting their outcomes. Research indicates that various factors, including socioeconomic status, access to healthcare, and environmental conditions, play a crucial role in the management and treatment of AD in these communities.
Children of color often experience barriers such as inadequate healthcare access, lack of insurance, and transportation challenges, which can hinder timely and effective treatment. These obstacles not only exacerbate the severity of the condition but also lead to a cycle of poor health outcomes and increased healthcare costs.
Addressing these social determinants is essential for improving the quality of care for pediatric patients with AD. Initiatives aimed at increasing awareness, enhancing access to specialists, and providing community support can significantly impact the management of atopic dermatitis in these vulnerable populations. By prioritizing these factors, healthcare systems can work towards achieving equitable health outcomes for all children, regardless of their background.
August 11, 2026 - 17:11
Dietitian Shares No. 1 Plant-Based Protein to Boost Brain HealthWhen people think about protein for brain health, they often picture eggs or salmon. But a growing number of nutrition experts are pointing to a humble plant source that does double duty: it fights...
August 11, 2026 - 04:10
What alcohol is consumed — not just how muchA recent analysis has shifted the conversation around drinking and health, focusing not just on how much people drink, but on what they are actually consuming. The findings suggest that the type of...
August 10, 2026 - 16:50
Nature Medicine Just Published the AI Mental Health Audit Framework the FDA Hasn’t Written YetA new framework for evaluating artificial intelligence chatbots used in mental health care has been published in Nature Medicine, offering a structured method for clinical trials that the FDA has...
August 9, 2026 - 18:35
The Watch: Microplastics Linked To Fatty Liver DiseaseA new study has drawn a direct line between microplastics and non-alcoholic fatty liver disease, with the most common type of plastic used in food packaging showing up in liver tissue samples....